VCM
DNTH icon

Versant Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Versant Capital Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$528 Buy
+6
New +$623 ﹤0.01% 2753

Other funds holding DNTH

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Versant Capital Management's DNTH Position: Q3 2026 in Review

Versant Capital Management opened a new position in Dianthus Therapeutics (DNTH) in Q3 2026: 6 shares worth $528. The stake represents ﹤0.01% of the portfolio and ranks #2753 among its holdings.

5 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • Versant Capital Management held 6 shares of Dianthus Therapeutics worth $528 as of Q3 2026.
  • Dianthus Therapeutics was a new Versant Capital Management position in Q3 2026.
  • Dianthus Therapeutics made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2753 holding.
  • 5 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.